Biotech Values

[zebra4o1]

Good point about the reported p-values being less than 0.05. - not sure what is going there. In the FDA briefing material, p values of 0.02 and below are highlighted in yellow, while p = 0.03 or higher are not highlighted.

Kind of sad looking at the trial results graphs which show that all this treatment does is slow down the progression of the disease. It doesn't stop vision loss or improve vision. Not saying it shouldn't be approved, but this definately isn't a silver bullet.